tiprankstipranks
Diaceutics (DE:7DC)
FRANKFURT:7DC
Germany Market
7DC
Diaceutics
RESEARCH TOOLSreports

Diaceutics (7DC) Ratios

0 Followers

Diaceutics Ratios

DE:7DC's free cash flow for Q4 2025 was £0.68. For the 2025 fiscal year, DE:7DC's free cash flow was decreased by £ and operating cash flow was £0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.43 3.43 3.80 6.40 8.23
Quick Ratio
 3.43 3.43 3.80 6.40 8.23
Cash Ratio
 0.86 0.86 1.64 3.80 5.29
Solvency Ratio
 0.53 0.62 0.33 0.54 0.65
Operating Cash Flow Ratio
 0.15 0.17 0.08 0.30 1.37
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 41.52
Net Current Asset Value
£ 19.83M£ 19.83M£ 20.77M£ 22.48M£ 25.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.02 0.03 0.03
Debt-to-Equity Ratio
 0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
 0.03 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.24 1.24 1.22 1.14 1.14
Debt Service Coverage Ratio
 81.05 102.33 55.15 46.23 15.32
Interest Coverage Ratio
 -3.66 4.59 -45.46 -45.73 4.71
Debt to Market Cap
 0.00 0.00 0.00 0.00 <0.01
Interest Debt Per Share
 0.01 0.01 0.01 0.02 0.02
Net Debt to EBITDA
 -1.26 -1.02 -4.21 -6.55 -5.13
Profitability Margins
Gross Profit Margin
73.80%67.97%87.91%83.15%71.97%
EBIT Margin
-0.11%0.69%-5.77%-10.19%3.08%
EBITDA Margin
12.76%15.81%8.62%9.95%18.50%
Operating Profit Margin
-0.55%0.69%-7.63%-12.73%2.95%
Pretax Profit Margin
0.79%0.62%-5.93%-10.29%2.89%
Net Profit Margin
0.25%0.25%-5.30%-7.37%3.71%
Continuous Operations Profit Margin
0.25%0.25%-5.30%-7.37%3.71%
Net Income Per EBT
32.12%40.42%89.26%71.62%128.37%
EBT Per EBIT
-142.45%90.23%77.72%80.78%98.09%
Return on Assets (ROA)
0.19%0.19%-3.50%-3.77%1.50%
Return on Equity (ROE)
0.25%0.24%-4.27%-4.28%1.70%
Return on Capital Employed (ROCE)
-0.51%0.64%-6.01%-7.19%1.29%
Return on Invested Capital (ROIC)
-0.16%0.26%-5.34%-5.13%1.28%
Return on Tangible Assets
0.29%0.29%-5.13%-5.62%2.19%
Earnings Yield
0.08%0.09%-1.61%-2.38%1.14%
Efficiency Ratios
Receivables Turnover
 1.83 1.83 2.15 2.34 1.87
Payables Turnover
 6.55 8.01 3.19 3.75 7.20
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 23.10 23.10 19.16 12.48 9.32
Asset Turnover
 0.77 0.77 0.66 0.51 0.40
Working Capital Turnover Ratio
 1.97 1.81 1.42 0.93 0.71
Cash Conversion Cycle
 143.41 153.56 55.56 58.60 144.46
Days of Sales Outstanding
 199.12 199.12 169.81 155.96 195.13
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 55.72 45.56 114.25 97.35 50.67
Operating Cycle
 199.12 199.12 169.81 155.96 195.13
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 0.02 <0.01 0.02 0.06
Free Cash Flow Per Share
 0.01 0.02 -0.05 -0.04 <0.01
CapEx Per Share
 <0.01 <0.01 0.05 0.06 0.06
Free Cash Flow to Operating Cash Flow
 0.95 0.95 -6.12 -2.70 0.05
Dividend Paid and CapEx Coverage Ratio
 18.32 21.07 0.14 0.27 1.06
Capital Expenditure Coverage Ratio
 18.32 21.07 0.14 0.27 1.06
Operating Cash Flow Coverage Ratio
 1.13 1.30 0.61 1.09 3.87
Operating Cash Flow to Sales Ratio
 0.03 0.04 0.02 0.06 0.26
Free Cash Flow Yield
0.99%1.32%-3.76%-4.84%0.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 1.35K 1.16K -62.24 -41.97 87.75
Price-to-Sales (P/S) Ratio
 3.27 2.82 3.30 3.09 3.26
Price-to-Book (P/B) Ratio
 3.11 2.67 2.66 1.80 1.49
Price-to-Free Cash Flow (P/FCF) Ratio
 102.17 75.98 -26.62 -20.68 228.54
Price-to-Operating Cash Flow Ratio
 96.65 72.37 162.81 55.89 12.34
Price-to-Earnings Growth (PEG) Ratio
 10.50 -11.04 25.77 0.12 3.09
Price-to-Fair Value
 3.11 2.67 2.66 1.80 1.49
Enterprise Value Multiple
 24.35 16.79 34.01 24.51 12.48
Enterprise Value
 118.21M 102.07M 94.31M 57.82M 45.02M
EV to EBITDA
 24.10 16.79 34.01 24.51 12.48
EV to Sales
 3.08 2.66 2.93 2.44 2.31
EV to Free Cash Flow
 96.11 71.63 -23.69 -16.31 161.95
EV to Operating Cash Flow
 90.86 68.23 144.86 44.10 8.75
Tangible Book Value Per Share
 0.29 0.29 0.29 0.30 0.32
Shareholders’ Equity Per Share
 0.48 0.48 0.47 0.48 0.51
Tax and Other Ratios
Effective Tax Rate
 0.68 0.60 0.11 0.28 -0.28
Revenue Per Share
 0.45 0.45 0.38 0.28 0.23
Net Income Per Share
 <0.01 <0.01 -0.02 -0.02 <0.01
Tax Burden
 0.32 0.40 0.89 0.72 1.28
Interest Burden
 -7.02 0.90 1.03 1.01 0.94
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.74 0.82 0.96 0.96 0.83
Stock-Based Compensation to Revenue
 0.01 0.02 0.03 0.02 0.03
Income Quality
 13.41 15.42 -0.34 -0.75 7.11
Currency in GBP